Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Cervical Pessary Reduces Rate of Preterm Birth

By HospiMedica International staff writers
Posted on 28 Dec 2017
A new study suggests that using a cervical pessary in pregnant women with short cervical length reduces the risk of spontaneous early birth.

Researchers at the University of Naples Federico II (Italy) conducted a randomized clinical trial of 300 women with singleton gestations, no previous spontaneous preterm births, and cervical lengths of 25 mm (or less) at 18-24 weeks of gestation, in order to test if use of a cervical pessary would reduce the rate of spontaneous preterm birth (less than 34 weeks of gestation). More...
In the 150 women in the study group the pessary was removed at week 36-37, or earlier if indicated. The primary endpoint was spontaneous preterm birth at less than 34 weeks of gestation.

The results showed that the primary end point of pre-term birth occurred in 11 women (7.3%) in the pessary group, and 23 women (15.3%) in the control group. The majority of women in both the study and the control groups were also treated with vaginal progesterone. The researchers found that during follow-up, the women in the pessary group had a higher rate of increased or new vaginal discharge (86.7%) versus 46% in the control group. The study was published on December 19, 2017, in JAMA.

“Among women without prior spontaneous preterm birth who had asymptomatic singleton pregnancies and short transvaginal cervical length, use of a cervical pessary, compared with no pessary use, resulted in a lower rate of spontaneous preterm birth at less than 34 weeks of gestation,” concluded lead author Gabriele Saccone, MD, and colleagues. “The results of this single-center, non-blinded study among selected pregnant women require confirmation in multicenter clinical trials.”

“Based on these data, clinicians might contemplate recommending pessaries for all women with a short cervix identified on an antenatal sonogram,” wrote Robert Silver, MD, and D. Ware Branch, MD, of the University of Utah (Salt Lake City, USA), in an accompanying editorial. “Nonetheless, it is important to be cautious prior to universal adoption of pessaries. In contrast to the results of the current trial, another study conducted with equivalent scientific rigor found no benefit to use of a pessary in women with short cervixes.”

Pregnant women are at risk of preterm birth when the cervix begins to efface (shorten) and dilate earlier than necessary. One of the options to prevent a late miscarriage or preterm birth is the cervical pessary, a small silicone ring-shaped device placed around the incompetent cervix early in the pregnancy in order to close it; it is removed later on when the risk of a preterm birth has passed. Other options include a cerclage suture stitched around the opening of the cervix around 12–14 weeks into the pregnancy.

Related Links:
University of Naples Federico II


Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gas Analyzer
GE SAM
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.